𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Some effects of concanavalin a on tumorigenesis in mice

✍ Scribed by D. Gericke; P. Chandra; A. Wacker


Publisher
Springer
Year
1971
Tongue
English
Weight
288 KB
Volume
58
Category
Article
ISSN
0028-1042

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibitory effects of curcumin on tumori
✍ Mou-Tuan Huang; Harold L. Newmark; Krystyna Frenkel πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

Curcumin (diferuloylmethane) , the naturally occurring yellow pigment in turmeric and curry, is isolated from the rhizomes of the plant Curcuma longa Linn. Curcumin inhibits tumorigenesis during both initiation and promotion (post-initiation) periods in several experimental animal models. Topical a

Effects of genetic background on tumorig
✍ Lawrence A. Donehower; Michele Harvey; Hannes Vogel; Mark J. McArthur; Charles A πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 566 KB

## Abstract Mice with disrupted germline __p53__ alleles have been engineered by us and others and have been shown to have enhanced susceptibility to spontaneous tumors of various types. We monitored a large number of __p53__‐deficient mice(__p53__+/βˆ’ and __p53__βˆ’/βˆ’) and their wild‐type littermates

Galectin-1 exerts immunomodulatory and p
✍ Luca Santucci; Stefano Fiorucci; Francesco Cammilleri; Giuseppe Servillo; Barbar πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 292 KB

## Galectin -1, an endogenous lectin with immunomodulatory activities, induces selective, Fas-independent apoptosis of activated T cells. The aim of the present study was to evaluate the effect galectin-1 exerts on concanavalin A (Con A)-induced hepatitis, a T-cell-dependent model of liver injury.

Chemopreventive effect of ERΞ²-Selective
✍ VΓ©ronique Giroux; GΓ©rald Bernatchez; Julie C. Carrier πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 547 KB

## Abstract Epidemiological and experimental evidence suggests that estrogen replacement therapy reduces the risk of colon cancer in postmenopausal women. Estrogen receptor beta (ERΞ²) is thought to be the principal mediator of the estrogen effect in the colon. Recent studies by our team suggested p